- Home
- Publications
- Publication Search
- Publication Details
Title
Nanocarrier Vaccines for SARS-CoV-2
Authors
Keywords
-
Journal
ADVANCED DRUG DELIVERY REVIEWS
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-01-11
DOI
10.1016/j.addr.2021.01.002
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Positive RT-PCR Test Results in Patients Recovered From COVID-19
- (2020) Lan Lan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Systematic Review of Lopinavir Therapy for SARS Coronavirus and MERS Coronavirus–A Possible Reference for Coronavirus Disease‐19 Treatment Option
- (2020) Tian‐Tian Yao et al. JOURNAL OF MEDICAL VIROLOGY
- Convalescent plasma as a potential therapy for COVID-19
- (2020) Long Chen et al. LANCET INFECTIOUS DISEASES
- COVID-19: combining antiviral and anti-inflammatory treatments
- (2020) Justin Stebbing et al. LANCET INFECTIOUS DISEASES
- An interactive web-based dashboard to track COVID-19 in real time
- (2020) Ensheng Dong et al. LANCET INFECTIOUS DISEASES
- Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
- (2020) Guangdi Li et al. NATURE REVIEWS DRUG DISCOVERY
- Engineering adeno-associated virus vectors for gene therapy
- (2020) Chengwen Li et al. NATURE REVIEWS GENETICS
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
- (2020) Qun Li et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Control of avian influenza in China: Strategies and lessons
- (2020) Shuo Liu et al. Transboundary and Emerging Diseases
- Remdesivir as a possible therapeutic option for the COVID-19
- (2020) Jaffar A. Al-Tawfiq et al. Travel Medicine and Infectious Disease
- The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
- (2020) Nature Microbiology
- The promise of mRNA vaccines: a biotech and industrial perspective
- (2020) Nicholas A. C. Jackson et al. npj Vaccines
- Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know
- (2020) Jinoos Yazdany et al. ANNALS OF INTERNAL MEDICINE
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
- (2020) Daniel Blanco-Melo et al. CELL
- COVID-19 infection: the perspectives on immune responses
- (2020) Yufang Shi et al. CELL DEATH AND DIFFERENTIATION
- Follow-up of asymptomatic patients with SARS-CoV-2 infection
- (2020) X. Zhou et al. CLINICAL MICROBIOLOGY AND INFECTION
- Emergence of Novel Coronavirus and COVID-19: whether to stay or die out?
- (2020) Asim Biswas et al. CRITICAL REVIEWS IN MICROBIOLOGY
- Emerging Therapeutic Potential of Mesenchymal Stem/Stromal Cells in Preeclampsia
- (2020) S. Suvakov et al. CURRENT HYPERTENSION REPORTS
- Cytokine storm intervention in the early stages of COVID-19 pneumonia
- (2020) Xinjuan Sun et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Herd Immunity: Understanding COVID-19
- (2020) Haley E. Randolph et al. IMMUNITY
- SARS-CoV-2 Vaccines: Status Report
- (2020) Fatima Amanat et al. IMMUNITY
- Lack of Antiviral Activity of Darunavir against SARS-CoV-2
- (2020) Sandra De Meyer et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Convalescent Plasma to Treat COVID-19
- (2020) John D. Roback et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
- (2020) James M. Sanders et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- COVID-19: Herd Immunity and Convalescent Plasma Transfer Therapy
- (2020) Kirtimaan Syal JOURNAL OF MEDICAL VIROLOGY
- TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib
- (2020) Dandan Wu et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
- (2020) Feng-Cai Zhu et al. LANCET
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Profile of a killer: the complex biology powering the coronavirus pandemic
- (2020) David Cyranoski NATURE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Developing Covid-19 Vaccines at Pandemic Speed
- (2020) Nicole Lurie et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Infection in Children
- (2020) Xiaoxia Lu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Compassionate Use of Remdesivir for Patients with Severe Covid-19
- (2020) Jonathan Grein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Harnessing innate immunity to eliminate SARS-CoV-2 and ameliorate COVID-19 disease
- (2020) Rachel M. Golonka et al. PHYSIOLOGICAL GENOMICS
- News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine
- (2020) Lynne Peeples PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immune responses and pathogenesis of SARS‐CoV ‐2 during an outbreak in Iran: Comparison with SARS and MERS
- (2020) Mohsen Rokni et al. REVIEWS IN MEDICAL VIROLOGY
- A strategic approach to COVID-19 vaccine R&D
- (2020) Lawrence Corey et al. SCIENCE
- Development of an inactivated vaccine candidate for SARS-CoV-2
- (2020) Qiang Gao et al. SCIENCE
- Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
- (2020) Stephen M. Kissler et al. SCIENCE
- Combination immunotherapy with anti-PD-L1 antibody and depletion of regulatory T cells during acute viral infections results in improved virus control but lethal immunopathology
- (2020) Paul David et al. PLoS Pathogens
- Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines
- (2020) Lynda Coughlan Frontiers in Immunology
- Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases
- (2020) Cynthia Liu et al. ACS Central Science
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
- (2020) Jia Liu et al. Cell Discovery
- Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications
- (2020) Young Hun Chung et al. ADVANCED DRUG DELIVERY REVIEWS
- Regulatory T Cells for Treating Patients With COVID-19 and Acute Respiratory Distress Syndrome: Two Case Reports
- (2020) Douglas E. Gladstone et al. ANNALS OF INTERNAL MEDICINE
- A Thermostable mRNA Vaccine against COVID-19
- (2020) Na-Na Zhang et al. CELL
- Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes
- (2020) Shengli Xia et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Herd immunity – estimating the level required to halt the COVID-19 epidemics in affected countries
- (2020) Kin On Kwok et al. JOURNAL OF INFECTION
- The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections
- (2020) Jatin Machhi et al. Journal of Neuroimmune Pharmacology
- Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2020) Feng-Cai Zhu et al. LANCET
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- (2020) Pedro M Folegatti et al. LANCET
- Innovation Lessons From the COVID-19 Pandemic
- (2020) Gianrico Farrugia et al. MAYO CLINIC PROCEEDINGS
- Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders
- (2020) Jatin Machhi et al. Molecular Neurodegeneration
- Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity
- (2020) Qiangzhe Zhang et al. NANO LETTERS
- Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
- (2020) Noe B. Mercado et al. NATURE
- ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
- (2020) Neeltje van Doremalen et al. NATURE
- Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults
- (2020) Mark J. Mulligan et al. NATURE
- COVID-19 vaccine development and a potential nanomaterial path forward
- (2020) Matthew D. Shin et al. Nature Nanotechnology
- Neurological immunotherapy in the era of COVID-19 — looking for consensus in the literature
- (2020) Catharina Korsukewitz et al. Nature Reviews Neurology
- Hydroxychloroquine for the Prevention of Covid-19 — Searching for Evidence
- (2020) Myron S. Cohen NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
- (2020) David R. Boulware et al. NEW ENGLAND JOURNAL OF MEDICINE
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19
- (2020) Wei Luo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice
- (2020) Paul F. McKay et al. Nature Communications
- Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs
- (2020) Jesús Zepeda-Cervantes et al. Frontiers in Immunology
- Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies
- (2020) Marisa Market et al. Frontiers in Immunology
- Potential Indirect Effects of the COVID-19 Pandemic on Use of Emergency Departments for Acute Life-Threatening Conditions — United States, January–May 2020
- (2020) Samantha J. Lange et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Targeting HIV Env immunogens to B cell follicles in nonhuman primates through immune complex or protein nanoparticle formulations
- (2020) Jacob T. Martin et al. npj Vaccines
- COVID-19 Vaccine Frontrunners and Their Nanotechnology Design
- (2020) Young Hun Chung et al. ACS Nano
- Engineering Antiviral Vaccines
- (2020) Xingwu Zhou et al. ACS Nano
- A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice
- (2020) Jing Lu et al. CELL RESEARCH
- COVID-19 reinfection or relapse: an intriguing dilemma
- (2020) Manu Madan et al. CLINICAL RHEUMATOLOGY
- Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses
- (2020) Tania Gupta et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
- (2020) Denis Y Logunov et al. LANCET
- Vaccination strategies to combat novel corona virus SARS-CoV-2
- (2020) Satish Chandra Pandey et al. LIFE SCIENCES
- The false promise of herd immunity for COVID-19
- (2020) Christie Aschwanden NATURE
- COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
- (2020) Ugur Sahin et al. NATURE
- Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study
- (2020) Sean T. H. Liu et al. NATURE MEDICINE
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
- (2020) Evan J. Anderson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
- (2020) Cheryl Keech et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis
- (2020) Ashleigh Shannon et al. Nature Communications
- Swedish policy analysis for Covid-19
- (2020) Andrius Kavaliunas et al. Health Policy and Technology
- Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
- (2020) Jeffrey Seow et al. Nature Microbiology
- Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19
- (2020) Wesley H. Self et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
- (2020) Maheshi N Ramasamy et al. LANCET
- Synthetic biology for bioengineering virus-like particle vaccines
- (2019) Hayley K. Charlton Hume et al. BIOTECHNOLOGY AND BIOENGINEERING
- Emerging viruses and current strategies for vaccine intervention
- (2019) B. Afrough et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate—Two randomized Phase II clinical trials in 18 to 49 and ≥50 years old adults
- (2019) Stéphane Pillet et al. PLoS One
- Attenuation of Human Respiratory Viruses by Synonymous Genome Recoding
- (2019) Cyril Le Nouën et al. Frontiers in Immunology
- T Cell Responses Induced by DNA Vaccines Based on the DENV2 E and NS1 Proteins in Mice: Importance in Protection and Immunodominant Epitope Identification
- (2019) Paolla B. A. Pinto et al. Frontiers in Immunology
- Hepatitis E Virus (HEV)-Specific T Cell Receptor Cross-Recognition: Implications for Immunotherapy
- (2019) Chai Fen Soon et al. Frontiers in Immunology
- Synthetic self-assembling ADDomer platform for highly efficient vaccination by genetically encoded multiepitope display
- (2019) Charles Vragniau et al. Science Advances
- Comprehensive AAV capsid fitness landscape reveals a viral gene and enables machine-guided design
- (2019) Pierce J. Ogden et al. SCIENCE
- In silico and in vitro analysis of small molecules and natural compounds targeting the 3CL protease of feline infectious peritonitis virus
- (2019) Sirin Theerawatanasirikul et al. ANTIVIRAL RESEARCH
- Preparation of virus-like particle mimetic nanovesicles displaying the S protein of Middle East respiratory syndrome coronavirus using insect cells
- (2019) Tatsuya Kato et al. JOURNAL OF BIOTECHNOLOGY
- Recent Progress in Vaccine Development Against Chikungunya Virus
- (2019) Shan Gao et al. Frontiers in Microbiology
- Current challenges for cancer vaccine adjuvant development
- (2018) William S. Bowen et al. Expert Review of Vaccines
- Vaccination-induced herd immunity: Successes and challenges
- (2018) Michael L. Mallory et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Improved Titers against Influenza Drift Variants with a Nanoparticle Vaccine
- (2018) Vivek Shinde et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus
- (2018) Yao Deng et al. Emerging Microbes & Infections
- OUP accepted manuscript
- (2018) JOURNAL OF INFECTIOUS DISEASES
- Autophagy Is a Tolerance-Avoidance Mechanism that Modulates TCR-Mediated Signaling and Cell Metabolism to Prevent Induction of T Cell Anergy
- (2018) Enric Mocholi et al. Cell Reports
- Vaccination of poultry successfully eliminated human infection with H7N9 virus in China
- (2018) Xianying Zeng et al. Science China-Life Sciences
- Novel viral vectors in infectious diseases
- (2017) Ian R. Humphreys et al. IMMUNOLOGY
- Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I/II multicenter clinical trial
- (2017) Chongsheng Qian et al. Journal of Hematology & Oncology
- Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses
- (2017) Dustin Siegel et al. JOURNAL OF MEDICINAL CHEMISTRY
- Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
- (2017) Yousuke FURUTA et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection
- (2017) Lan Jiaming et al. VACCINE
- Designing liposomal adjuvants for the next generation of vaccines
- (2016) Yvonne Perrie et al. ADVANCED DRUG DELIVERY REVIEWS
- Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention
- (2016) Lindsey R. Baden et al. ANNALS OF INTERNAL MEDICINE
- Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease
- (2016) John Attanasio et al. IMMUNITY
- Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
- (2016) Anthony L. Cunningham et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccine development: From concept to early clinical testing
- (2016) Anthony L. Cunningham et al. VACCINE
- Progress Toward Polio Eradication — Worldwide, 2015–2016
- (2016) Michelle Morales et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization
- (2016) Karl D. Brune et al. Scientific Reports
- Formulation and stabilization of recombinant protein based virus-like particle vaccines
- (2015) Nishant K. Jain et al. ADVANCED DRUG DELIVERY REVIEWS
- Tocilizumab in systemic juvenile idiopathic arthritis in a real-world clinical setting: results from 1 year of postmarketing surveillance follow-up of 417 patients in Japan
- (2015) Shumpei Yokota et al. ANNALS OF THE RHEUMATIC DISEASES
- Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial
- (2015) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus
- (2015) Naru Zhang et al. Cellular & Molecular Immunology
- Enveloped virus-like particle platforms: vaccines of the future?
- (2015) Fabien Pitoiset et al. Expert Review of Vaccines
- Exploring the role of polymer structure on intracellular nucleic acid delivery via polymeric nanoparticles
- (2015) Corey J. Bishop et al. JOURNAL OF CONTROLLED RELEASE
- Cutting Edge: Antimalarial Drugs Inhibit IFN-β Production through Blockade of Cyclic GMP-AMP Synthase–DNA Interaction
- (2015) Jie An et al. JOURNAL OF IMMUNOLOGY
- Production of Biopharmaceuticals in E. coli: Current Scenario and Future Perspectives
- (2015) Mohammed N. Baeshen et al. JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
- Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S Vaccine
- (2015) Daniel Shouval et al. MEDICAL MICROBIOLOGY AND IMMUNOLOGY
- A Novel Virus-Like Particle Based Vaccine Platform Displaying the Placental Malaria Antigen VAR2CSA
- (2015) Susan Thrane et al. PLoS One
- Toward an HIV vaccine: A scientific journey
- (2015) A. S. Fauci et al. SCIENCE
- Live attenuated vaccines: Historical successes and current challenges
- (2015) Philip D. Minor VIROLOGY
- Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination
- (2015) Aline Baldo et al. Human Vaccines & Immunotherapeutics
- Chloroquine Inhibits Autophagy to Potentiate Antiestrogen Responsiveness in ER+ Breast Cancer
- (2014) K. L. Cook et al. CLINICAL CANCER RESEARCH
- Basic Biology of Adeno-Associated Virus (AAV) Vectors Used in Gene Therapy
- (2014) Balaji Balakrishnan et al. CURRENT GENE THERAPY
- Adenovirus Vectors for Gene Therapy, Vaccination and Cancer Gene Therapy
- (2014) William Wold et al. CURRENT GENE THERAPY
- Immunomodulatory properties of the vaccine adjuvant alum
- (2014) Ewa Oleszycka et al. CURRENT OPINION IN IMMUNOLOGY
- Vaccines for the 21st century
- (2014) I. Delany et al. EMBO Molecular Medicine
- Approaches to Tuberculosis Mucosal Vaccine Development Using Nanoparticles and Microparticles: A Review
- (2014) Liliana Aranha Caetano et al. Journal of Biomedical Nanotechnology
- A Special Issue on Reviews in Nanomedicine, Drug Delivery and Vaccine Development
- (2014) Hari Singh Nalwa Journal of Biomedical Nanotechnology
- Effects of Toll-Like Receptor Stimulation on Eosinophilic Infiltration in Lungs of BALB/c Mice Immunized with UV-Inactivated Severe Acute Respiratory Syndrome-Related Coronavirus Vaccine
- (2014) N. Iwata-Yoshikawa et al. JOURNAL OF VIROLOGY
- Tailoring Subunit Vaccine Immunity with Adjuvant Combinations and Delivery Routes Using the Middle East Respiratory Coronavirus (MERS-CoV) Receptor-Binding Domain as an Antigen
- (2014) Jiaming Lan et al. PLoS One
- Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice
- (2014) Christopher M. Coleman et al. VACCINE
- Refining the Balance of Attenuation and Immunogenicity of Respiratory Syncytial Virus by Targeted Codon Deoptimization of Virulence Genes
- (2014) J. Meng et al. mBio
- Immunobiology of Influenza Vaccines
- (2013) Margarita M. Gomez Lorenzo et al. CHEST
- Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells
- (2013) Aleš Berlec et al. JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY
- Identification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Development
- (2013) L. Du et al. JOURNAL OF VIROLOGY
- Induction of innate immunity in lungs with virus-like nanoparticles leads to protection against influenza and Streptococcus pneumoniae challenge
- (2013) Claudia Mathieu et al. Nanomedicine-Nanotechnology Biology and Medicine
- Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling
- (2013) Gaurav Sahay et al. NATURE BIOTECHNOLOGY
- Vaccine adjuvant formulations: A pharmaceutical perspective
- (2013) Luis A. Brito et al. SEMINARS IN IMMUNOLOGY
- Virus-like particle-based human vaccines: quality assessment based on structural and functional properties
- (2013) Qinjian Zhao et al. TRENDS IN BIOTECHNOLOGY
- Evaluation of safety and immunogenicity of recombinant influenza hemagglutinin (H5/Indonesia/05/2005) formulated with and without a stable oil-in-water emulsion containing glucopyranosyl-lipid A (SE+GLA) adjuvant
- (2013) John J. Treanor et al. VACCINE
- A novel platform for virus-like particle-display of flaviviral envelope domain III: induction of Dengue and West Nile virus neutralizing antibodies
- (2013) Anthony JS Chua et al. Virology Journal
- Biodegradable Particles as Vaccine Delivery Systems: Size Matters
- (2012) Vijaya B. Joshi et al. AAPS Journal
- Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion
- (2012) Nathalie Garçon et al. Expert Review of Vaccines
- Dendritic cell-based vaccines: barriers and opportunities
- (2012) Jessica A Cintolo et al. Future Oncology
- Dendritic cell-based immunity and vaccination against hepatitis C virus infection
- (2012) Yun Zhou et al. IMMUNOLOGY
- Adoptive Transfer of Epstein-Barr Virus (EBV) Nuclear Antigen 1–Specific T Cells As Treatment for EBV Reactivation and Lymphoproliferative Disorders After Allogeneic Stem-Cell Transplantation
- (2012) Vanya Icheva et al. JOURNAL OF CLINICAL ONCOLOGY
- AF03, An Alternative Squalene Emulsion‐Based Vaccine Adjuvant Prepared by a Phase Inversion Temperature Method
- (2012) Marie‐Françoise Klucker et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Comparative Analysis of Simian Immunodeficiency Virus Gag-Specific Effector and Memory CD8+T Cells Induced by Different Adenovirus Vectors
- (2012) Wendy G. Tan et al. JOURNAL OF VIROLOGY
- Construction and Characterization of Virus-Like Particles: A Review
- (2012) Andris Zeltins MOLECULAR BIOTECHNOLOGY
- A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity
- (2012) Matthew D. J. Dicks et al. PLoS One
- Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development
- (2012) Natasha Kushnir et al. VACCINE
- Nanoemulsion W805EC improves immune responses upon intranasal delivery of an inactivated pandemic H1N1 influenza vaccine
- (2012) Subash C. Das et al. VACCINE
- MF59 oil-in-water emulsion in combination with a synthetic TLR4 agonist (E6020) is a potent adjuvant for a combination Meningococcus vaccine
- (2012) Manmohan Singh et al. Human Vaccines & Immunotherapeutics
- Thermal-sensitive hydrogel as adjuvant-free vaccine delivery system for H5N1 intranasal immunization
- (2011) Youbin Wu et al. BIOMATERIALS
- Aluminum Vaccine Adjuvants: Are they Safe?
- (2011) L. Tomljenovic et al. CURRENT MEDICINAL CHEMISTRY
- Viral vectors as vaccine platforms: deployment in sight
- (2011) Christine S Rollier et al. CURRENT OPINION IN IMMUNOLOGY
- Virus-Specific CD8+ T Cells Upregulate Programmed Death-1 Expression during Acute Friend Retrovirus Infection but Are Highly Cytotoxic and Control Virus Replication
- (2011) G. Zelinskyy et al. JOURNAL OF IMMUNOLOGY
- Lack of Peripheral Memory B Cell Responses in Recovered Patients with Severe Acute Respiratory Syndrome: A Six-Year Follow-Up Study
- (2011) F. Tang et al. JOURNAL OF IMMUNOLOGY
- Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinolines
- (2011) A. Kuznik et al. JOURNAL OF IMMUNOLOGY
- A West Nile Virus DNA Vaccine Utilizing a Modified Promoter Induces Neutralizing Antibody in Younger and Older Healthy Adults in a Phase I Clinical Trial
- (2011) Julie E. Ledgerwood et al. JOURNAL OF INFECTIOUS DISEASES
- Immunological mechanisms of vaccination
- (2011) Bali Pulendran et al. NATURE IMMUNOLOGY
- Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV
- (2011) Ye V. Liu et al. VACCINE
- Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity
- (2011) Sandra Morel et al. VACCINE
- A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR−/− mice upon lethal virus challenge
- (2011) Hani Boshra et al. VACCINE
- Viruses—from pathogens to vaccine carriers
- (2011) Juliana C Small et al. Current Opinion in Virology
- A DNA Vaccine against Chikungunya Virus Is Protective in Mice and Induces Neutralizing Antibodies in Mice and Nonhuman Primates
- (2011) Karthik Mallilankaraman et al. PLoS Neglected Tropical Diseases
- Production of recombinant proteins and metabolites in yeasts
- (2010) Danilo Porro et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Cellular Vaccine Approaches
- (2010) Dung T. Le et al. CANCER JOURNAL
- Virus-Like Particles as Particulate Vaccines
- (2010) Luigi Buonaguro et al. CURRENT HIV RESEARCH
- Virus-like particles in vaccine development
- (2010) António Roldão et al. Expert Review of Vaccines
- Rational design of cationic lipids for siRNA delivery
- (2010) Sean C Semple et al. NATURE BIOTECHNOLOGY
- Nanoparticle Delivery Systems in Cancer Vaccines
- (2010) Yogita Krishnamachari et al. PHARMACEUTICAL RESEARCH
- Virus engineering: functionalization and stabilization
- (2010) M. G. Mateu PROTEIN ENGINEERING DESIGN & SELECTION
- One dose of a porcine circovirus 2 subunit vaccine induces humoral and cell-mediated immunity and protects against porcine circovirus-associated disease under field conditions
- (2010) Paolo Martelli et al. VETERINARY MICROBIOLOGY
- Immunogenicity and Protective Efficacy in Mice and Hamsters of a β-Propiolactone Inactivated Whole Virus SARS-CoV Vaccine
- (2010) Anjeanette Roberts et al. VIRAL IMMUNOLOGY
- Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators
- (2009) Pernille Nordly et al. Expert Opinion on Drug Delivery
- MF59®-adjuvanted influenza vaccine (FLUAD®) in children: Safety and immunogenicity following a second year seasonal vaccination
- (2009) T. Vesikari et al. VACCINE
- Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: Effect of viremia levels and antiviral treatment
- (2008) Simona Urbani et al. JOURNAL OF HEPATOLOGY
- The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor
- (2008) Sarah E. Ewald et al. NATURE
- Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV
- (2008) Kumari G. Lokugamage et al. VACCINE
- Recombinant vector derived from live attenuated measles virus: Potential for flavivirus vaccines
- (2007) Samantha Brandler et al. COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started